Actelion Pharmaceuticals Ltd., a Janssen Pharmaceutical Company of Johnson & Johnson, is recruiting for a Global Labeling Product Leader. The position will be based at either of the following Actelion sites: US (Cherry Hill, NJ) or Switzerland (Allschwil).This position is open at Manager, Associate Director or Director level. Depending on the profile of the final candidate, the appropriate level will be applicable.
As part of the Janssen Pharmaceutical Companies of Johnson & Johnson, we are working to create a world without disease. Transforming lives by finding new and better ways to prevent, intercept, treat and cure disease inspires us. We bring together the best minds and pursue the most promising science. We collaborate with the world for the health of everyone in it. Actelion is a leader in the field of pulmonary arterial hypertension (PAH). Our portfolio of PAH treatments covers the spectrum of disease, from WHO Functional Class (FC) II-IV, with oral, inhaled and intravenous medications.
Actelion is a leader in the field of pulmonary arterial hypertension (PAH). Our portfolio of PAH treatments covers the spectrum of disease, from WHO Functional Class (FC) II through to FC IV, with oral, inhaled and intravenous medications.
The Global Labeling Product Leader (GLPL) will collaborate with functional areas to implement the global labeling strategy in line with the global regulatory strategy. The GLPL will lead the development and maintenance of the following through the company's labeling review and approval processes, ensuring high quality and compliance of labeling documents.
This role may collaborate with internal and external partners
If you are interested in making an impact by working in a culture of innovation, trust and teamwork, we welcome your application.